SEC Filing Summary for Nick Pizzie
2026-04-23SEC Filing 4 (0001193125-26-174412)
Nick Pizzie, Chief Financial Officer of Axsome Therapeutics, Inc., acquired 8,188 Performance Stock Units (PSUs) on April 21, 2026. These PSUs represent a contingent right to receive one share of the Issuer's common stock. The PSUs will vest upon the achievement of certain sales and commercial launch milestones, provided Mr. Pizzie remains in continuous service. The transaction was reported on a Form 4 filing. The price per share was $0.0, and the post-transaction shares owned are 8,188.